Carlos Augusto Monteiro, MD, PhD

Professor of Nutrition and Public Health
University of São Paulo
Sao Paulo, Sao Paulo, Brazil

Carlos A. Monteiro, MD, PhD, is a Professor of Nutrition and Public Health at the School of Public Health, University of Sao Paulo, Brazil, where he heads the Center for Epidemiological Studies in Health and Nutrition. His research lines include new methods in population nutritional and food intake assessment, epidemiology of all forms of malnutrition, dietary determinants of non-communicable diseases, and food processing and human health. On these subjects, he has published more than 250 journal articles that had more than 19,000 citations in the Web of Science (H index: 67). In the last four years (2018-2021), he was included in the Clarivate Analytics Global Highly Cited Researchers List. Since 2008, he is member of the Brazilian Academy of Sciences. He has served on numerous national and international nutrition expert panels and committees and, since 2010, he is a member of the WHO Nutrition Expert Advisory Group. In 2010, he received the Pan-American Health Organization Abraham Horwitz Award for Excellence in Leadership in Inter-American Health.

Presentation(s):

• Great Debates in Nutrition: Does the Concept of ‘Ultra-Processed Foods’ Help Inform Dietary Guidelines, Beyond Conventional Classification Systems?

  Tuesday, June 14, 2022
  2:00 PM – 3:30 PM ET

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Does the Concept of ‘Ultra-Processed Foods’ Help Inform Dietary Guidelines, Beyond Conventional Classification Systems? YES

  Tuesday, June 14, 2022
  2:10 PM – 2:35 PM ET

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Panel Discussion - Great Debates in Nutrition: Does the Concept of ‘Ultra-Processed Foods’ Help Inform Dietary Guidelines, Beyond Conventional Classification Systems?

  Tuesday, June 14, 2022
  3:10 PM – 3:25 PM ET

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.